In glioma, chaetocin was previously shown to induce ROS-mediated apoptosis through the Atm–Yap1 axis and Jnk-dependent metabolic adaptation, where chaetocin reduced lactate levels, ATP production and glucose uptake51. This evidence concerns the gene YAP1 and central nervous system cancer.